WallStSmart

American Well Corp (AMWL)vsDoximity Inc (DOCS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Doximity Inc generates 169% more annual revenue ($637.78M vs $237.38M). DOCS leads profitability with a 37.5% profit margin vs -37.0%. DOCS earns a higher WallStSmart Score of 66/100 (B-).

AMWL

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 6.7Quality: 7.0
Piotroski: 5/9Altman Z: -6.62

DOCS

Strong Buy

66

out of 100

Grade: B-

Growth: 5.3Profit: 9.0Value: 8.0Quality: 8.3
Piotroski: 6/9Altman Z: 5.72
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMWLUndervalued (+86.0%)

Margin of Safety

+86.0%

Fair Value

$30.83

Current Price

$7.97

$22.86 discount

UndervaluedFair: $30.83Overvalued
DOCSUndervalued (+44.4%)

Margin of Safety

+44.4%

Fair Value

$46.71

Current Price

$25.98

$20.73 discount

UndervaluedFair: $46.71Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMWL2 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

DOCS5 strengths · Avg: 9.4/10
Profit MarginProfitability
37.5%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
38.9%10/10

Strong operational efficiency at 38.9%

Altman Z-ScoreHealth
5.7210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
23.8%9/10

Every $100 of equity generates 24 in profit

PEG RatioValuation
0.698/10

Growing faster than its price suggests

Areas to Watch

AMWL4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$133.17M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-31.8%2/10

ROE of -31.8% — below average capital efficiency

Revenue GrowthGrowth
-17.9%2/10

Revenue declined 17.9%

DOCS1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMWL

The strongest argument for AMWL centers on Price/Book, Debt/Equity.

Bull Case : DOCS

The strongest argument for DOCS centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 37.5% and operating margin at 38.9%. PEG of 0.69 suggests the stock is reasonably priced for its growth.

Bear Case : AMWL

The primary concerns for AMWL are EPS Growth, Market Cap, Return on Equity.

Bear Case : DOCS

The primary concerns for DOCS are EPS Growth.

Key Dynamics to Monitor

AMWL profiles as a turnaround stock while DOCS is a mature play — different risk/reward profiles.

AMWL carries more volatility with a beta of 1.53 — expect wider price swings.

DOCS is growing revenue faster at 9.8% — sustainability is the question.

DOCS generates stronger free cash flow (59M), providing more financial flexibility.

Bottom Line

DOCS scores higher overall (66/100 vs 34/100), backed by strong 37.5% margins. AMWL offers better value entry with a 86.0% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Well Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

Doximity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.

Want to dig deeper into these stocks?